rheumatoid arthritis
Augurex Wins Health Canada Approval for Autoimmune Condition Test
The blood test detects a protein biomarker to aid in the diagnosis of axial spondyloarthritis, which is often mistaken for lower back pain.
Canada's Augurex Gets UK Conformity Authorization for Rheumatoid Arthritis Diagnosis, Management Test
The test measures a protein biomarker and can be used to diagnose and manage patients with the progressive autoimmune disorder.
Exagen Posts Flat to Slight Decline in Preliminary Q4 Report, Gets Conditional NY Approval
The company received conditional approval from New York state for its new systemic lupus erythematosus and rheumatoid arthritis biomarker assays.
Augurex Inks Agreement With Quest Diagnostics to Validate and Sell Rheumatoid Arthritis Test
The test will measure levels of the 14-3-3eta protein, which is used in the diagnosis and management of inflammatory diseases including rheumatoid arthritis.
Australia's Colonial Foundation Commits A$21M for Inflammatory Disease Dx Research Center
The new center will use spatial omics technology and be led by the Royal Melbourne Hospital and the Walter and Eliza Hall Institute of Medical Research (WEHI).
Jun 29, 2022
Feb 24, 2022
Feb 24, 2022
Scipher Medicine Nabs $110M in Financing
Mar 24, 2021
Scipher Medicine Raises $82M in Series C Financing
May 11, 2020
Exagen Q1 Revenues Grow 3 Percent
Apr 25, 2020